Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Inventory (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Inventory for 6 consecutive years, with $70.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 25.86% to $70.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.7 million, a 25.86% increase, with the full-year FY2025 number at $70.7 million, up 25.86% from a year prior.
  • Inventory was $70.7 million for Q4 2025 at PROCEPT BioRobotics, up from $67.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $70.7 million in Q4 2025 to a low of $10.4 million in Q3 2021.
  • A 5-year average of $37.2 million and a median of $40.7 million in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: surged 209.47% in 2023, then grew 2.88% in 2024.
  • PROCEPT BioRobotics' Inventory stood at $13.1 million in 2021, then skyrocketed by 117.11% to $28.5 million in 2022, then soared by 39.28% to $39.8 million in 2023, then soared by 41.28% to $56.2 million in 2024, then grew by 25.86% to $70.7 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Inventory are $70.7 million (Q4 2025), $67.0 million (Q2 2025), and $56.2 million (Q4 2024).